Fampridine-SR – Treatment for Multiple Sclerosis
Key Data:
Drug (brand/generic)
Fampridine-SR (4-aminopyridine)
Company/licensee
Acorda Therapeutics
Therapy class
Potassium channel blocker
Product description
Selective neuronal potassium (K+) channel blocker
Current indication
Treatment of MS
Market sector
CNS
Development status
Phase III
